SLC5A2 and metabolic syndrome: Therefore, all together, SGLT2 inhibitor DAPA may inhibit a myocardial NHE leading to increased mitochondrial [Ca2+] and decreased cytoplasmic [Ca2+]i and [H+]i through mitochondrial NCX activity in MetS rat heart.